Table 5 Analysis and results of ALK and ROS1 markers in EGFR non-mutated patients
Total | Non-squamous | Squamous | p-value | |
|---|---|---|---|---|
ALK | ||||
Not analysed | 803 (15,9%) | 735 (15,4%) | 68 (25,3%) | |
Analysed | 4.250 (84,1%) | 4.049 (84,6%) | 201 (74,7%) | < 0,001 |
Negative | 4.039 (95,0%) | 3.840 (94,8%) | 199 (99,0%) | |
Positive | 211 (5,0%) | 209 (5,2%) | 2 (1,0%) | 0,004 |
ROS1 | ||||
Not analysed | 2.702 (53,5%) | 2.557 (53,4%) | 145 (53,9%) | |
Analysed | 2.351 (46,5%) | 2.227 (46,6%) | 124 (46,5%) | 0,900 |
Negative | 2.284 (97,2%) | 2.164 (97,2%) | 120 (96,8%) | |
Positive | 67 (2,8%) | 63 (2,8%) | 4 (3,2%) | 0,778 |